Skip to Content

225 (Propafenone Hydrochloride Extended-Release 225 mg)

Pill with imprint 225 is Brown & White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by Vitruvias Therapeutics.

Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; ventricular tachycardia; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 225

Propafenone Hydrochloride Extended-Release

Imprint
225
Strength
225 mg
Color
Brown & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Vitruvias Therapeutics
Manufacturer
Haimen Pharma Inc.
National Drug Code (NDC)
69680-0130

Get help with Imprint Code FAQs.

Related Images for "225"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.